Differences between a cell signaling protein in humans and animals may explain the unexpectedly severe reaction in six young men given TeGenero’s new drug TGN1412 in a clinical trial in Britain, an expert said on Sunday.
Differences between a cell signaling protein in humans and animals may explain the unexpectedly severe reaction in six young men given TeGenero’s new drug TGN1412 in a clinical trial in Britain, an expert said on Sunday.
